title: Noradrenaline - Neonatal Intensive Care Drug Manual
text: |
  Neonatal Intensive Care Drug Manual
  |
  bet | 391/654 | Sana | 03.01.2022 | Hajmi | 1,5 Mb. | | #14803 |
  Noradrenaline
  Revision Date : 24-12-2020
  |
  Approved: TC, KOH
  |
  Alert
  |
  Prescribe as noradrenaline base. Noradrenaline acid tartrate 2 mg/mL is equivalent to noradrenaline base 1 mg/mL (1:1,000)
  |
  Indication
  |
  Treatment of hyperdynamic shock secondary to sepsis. [1]
  Second line inotrope for treatment of fluid-refractory hypotensive shock in the setting of low systemic vascular resistance (SVR).[1]
  Circulatory failure in the setting of pulmonary hypertension refractory to nitric oxide.[2]
  |
  Action
  |
  Catecholamine with strong vascular alpha and cardiac beta-adrenergic action, moderate cardiac alpha-adrenergic actions.[3]
  Noradrenaline increases blood pressure, urine output and reduces lactate in newborns with septic shock refractory to volume expansion and other inotropes.[4]
  Noradrenaline increases systemic and pulmonary pressures, increases pulmonary blood flow and improves systemic oxygen saturation in newborn infants with pulmonary hypertension and circulatory failure. [2]
  |
  |
  |
  | |